Literature DB >> 8043299

Rat mammary arginase: isolation and characterization.

C P Jenkinson1, M R Grigor.   

Abstract

The extrahepatic arginase, AII, from rat mammary gland was isolated and its properties investigated and compared with those of the hepatic arginase, AI. Mammary arginase activity increased 300% at mid-lactation, an increase unaccompanied by an increase in liver arginase activity. Mammary gland contained two isozymes, separable by ion exchange chromatography. The major form, AII, was purified 103-fold and antisera were raised against it. A 1300-fold purification was achieved temporarily but the enzyme was unstable. Arginase AII was kinetically similar to AI: both had pH optima of 10 and Kms for L-arginine of 12-14 mM. Arginase AII differed from AI in having a near-neutral pI and a slightly larger subunit size (39,800 Da compared to 38,900 Da by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)). Solution immunoprecipitation studies revealed that virtually all of the arginase present in liver was type AI, whereas kidney and mammary gland contained both isozymes. Western immunoblotting showed that the amount of immunoreactive mammary arginase AII protein increased at mid-lactation in parallel with the increase in activity. This suggests that the elevated arginase activity is due to de novo protein synthesis and/or reduced protein degradation, rather than activation of arginase.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8043299     DOI: 10.1006/bmmb.1994.1020

Source DB:  PubMed          Journal:  Biochem Med Metab Biol        ISSN: 0885-4505


  9 in total

1.  Role of arginase in impairing relaxation of lung parenchyma of hyperoxia-exposed neonatal rats.

Authors:  Nuzhat K M Ali; Anjum Jafri; Ramadan B Sopi; Y S Prakash; Richard J Martin; Syed I A Zaidi
Journal:  Neonatology       Date:  2011-09-23       Impact factor: 4.035

2.  Characterization of cationic amino acid transporters (hCATs) 1 and 2 in human skin.

Authors:  Kristin Jaeger; Friedrich Paulsen; Johannes Wohlrab
Journal:  Histochem Cell Biol       Date:  2008-01-03       Impact factor: 4.304

Review 3.  The human arginases and arginase deficiency.

Authors:  R Iyer; C P Jenkinson; J G Vockley; R M Kern; W W Grody; S Cederbaum
Journal:  J Inherit Metab Dis       Date:  1998       Impact factor: 4.982

Review 4.  Arginine metabolism: nitric oxide and beyond.

Authors:  G Wu; S M Morris
Journal:  Biochem J       Date:  1998-11-15       Impact factor: 3.857

5.  Mouse model for human arginase deficiency.

Authors:  Ramaswamy K Iyer; Paul K Yoo; Rita M Kern; Nora Rozengurt; Rosemarie Tsoa; William E O'Brien; Hong Yu; Wayne W Grody; Stephen D Cederbaum
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

6.  Melatonin ameliorates cerebral vasospasm after experimental subarachnoidal haemorrhage correcting imbalance of nitric oxide levels in rats.

Authors:  M A Aladag; Y Turkoz; H Parlakpinar; H Ozen; M Egri; S C Unal
Journal:  Neurochem Res       Date:  2009-05-05       Impact factor: 3.996

7.  Purification, properties and alternate substrate specificities of arginase from two different sources: Vigna catjang cotyledon and buffalo liver.

Authors:  Snehal Dabir; Pankaj Dabir; Baburao Somvanshi
Journal:  Int J Biol Sci       Date:  2005-08-01       Impact factor: 6.580

8.  Unique hepatic cytosolic arginase evolved independently in ureogenic freshwater air-breathing teleost, Heteropneustes fossilis.

Authors:  Shilpee Srivastava; B K Ratha
Journal:  PLoS One       Date:  2013-06-20       Impact factor: 3.240

9.  Metabolic determinants of the immune modulatory function of neural stem cells.

Authors:  Denise Drago; Veronica Basso; Edoardo Gaude; Giulio Volpe; Luca Peruzzotti-Jametti; Angela Bachi; Giovanna Musco; Annapaola Andolfo; Christian Frezza; Anna Mondino; Stefano Pluchino
Journal:  J Neuroinflammation       Date:  2016-09-02       Impact factor: 8.322

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.